Bevacizumab for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

AuthID
P-002-SZN
1
Author(s)
Document Type
Review
Year published
2011
Published
in CURRENT OPINION IN ONCOLOGY, ISSN: 1040-8746
Volume: 23, Issue: SUPPL. 1, Pages: S3-S9 (7)
Indexing
Publication Identifiers
Pubmed: 21490481
Scopus: 2-s2.0-79955005438
Wos: WOS:000292355800002
Source Identifiers
ISSN: 1040-8746
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.